Market Research Report
Colorectal Cancer Therapeutics: Global Markets
|Published by||BCC Research||Product code||819225|
|Published||Content info||124 Pages
Delivery time: 1-2 business days
|Colorectal Cancer Therapeutics: Global Markets|
|Published: March 29, 2019||Content info: 124 Pages||
The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.1% for the period 2018 to 2023.
Chemotherapy as a segment of the global colorectal cancer therapeutics market is expected to grow from $11.2 billion in 2018 to $14.8 billion in 2023 at a CAGR of 5.8% for the period 2018 to 2023.
Targeted therapy as a segment of the global colorectal cancer therapeutics market is expected to grow from $1.1 billion in 2018 to $1.6 billion in 2023 at a CAGR of 8.1% for the period 2018 to 2023.
This report is a business analysis that examines market trends for colorectal cancer therapeutics. The report includes sections on the following topics -
This report captures colorectal cancer therapeutics market revenue for different regions by treatment type, i.e., chemotherapy, targeted therapy and immunotherapy used for treating the disease. A detailed colorectal cancer therapeutics market analysis covers the regions of North America, Europe, Asia-Pacific, and Rest of World.
Market values are provided using 2017 as base year, 2018 as estimated year, and 2023 as forecasted year. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.